Literature DB >> 16808433

Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4.

James J Pesavento1, Craig A Mizzen, Neil L Kelleher.   

Abstract

Here we show that fragment ion abundances from dissociation of ions created from mixtures of multiply modified histone H4 (11 kDa) or of N-terminal synthetic peptides (2 kDa) correspond to their respective intact ion abundances measured by Fourier transform mass spectrometry. Isomeric mixtures of modified forms of the same protein are resolved and quantitated with a precision of </=5% using the relative ratios of their fragment ions, with intact protein ions created by electrospray greatly easing many of the systematic biases that more strongly affect small peptides (e.g., differences in ionization efficiency and ion m/z values). The ion fragmentation methods validated here are directly extensible to intact human proteins to derive quantitative information on the highly related and often isomeric protein forms created by combinatorial arrays of posttranslational modifications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808433     DOI: 10.1021/ac0600050

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  108 in total

1.  New protein footprinting: fast photochemical iodination combined with top-down and bottom-up mass spectrometry.

Authors:  Jiawei Chen; Weidong Cui; Daryl Giblin; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-06       Impact factor: 3.109

Review 2.  Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?

Authors:  Mariana D Plazas-Mayorca; Kent E Vrana
Journal:  J Proteome Res       Date:  2010-09-09       Impact factor: 4.466

Review 3.  The significance, development and progress of high-throughput combinatorial histone code analysis.

Authors:  Nicolas L Young; Peter A Dimaggio; Benjamin A Garcia
Journal:  Cell Mol Life Sci       Date:  2010-08-04       Impact factor: 9.261

4.  Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression.

Authors:  Yupeng Zheng; Luca Fornelli; Philip D Compton; Seema Sharma; Jesse Canterbury; Christopher Mullen; Vlad Zabrouskov; Ryan T Fellers; Paul M Thomas; Jonathan D Licht; Michael W Senko; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2015-08-13       Impact factor: 5.911

5.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

6.  Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle.

Authors:  James J Pesavento; Hongbo Yang; Neil L Kelleher; Craig A Mizzen
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

Review 7.  Decoding protein modifications using top-down mass spectrometry.

Authors:  Nertila Siuti; Neil L Kelleher
Journal:  Nat Methods       Date:  2007-10       Impact factor: 28.547

8.  Identification of two SET domain proteins required for methylation of lysine residues in yeast ribosomal protein Rpl42ab.

Authors:  Kristofor J Webb; Arthur Laganowsky; Julian P Whitelegge; Steven G Clarke
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

9.  Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.

Authors:  Ying Peng; Xin Chen; Han Zhang; Qingge Xu; Timothy A Hacker; Ying Ge
Journal:  J Proteome Res       Date:  2012-12-20       Impact factor: 4.466

Review 10.  Mixed-mode hydrophilic interaction/cation-exchange chromatography (HILIC/CEX) of peptides and proteins.

Authors:  Colin T Mant; Robert S Hodges
Journal:  J Sep Sci       Date:  2008-08       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.